Up to date, a growing body of evidence has associated the TLR4/MyD88/NF-κB pathway within the brain with pathological hypertension, whereas RAS and sympathetic nervous system (SNS) are involved in regulating blood pressure. Here, NFKB1 is linked to hypertensive disorder.